{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T12:35:14Z","timestamp":1783341314393,"version":"3.54.6"},"reference-count":37,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Cancer Institute of the National Institutes of Health","award":["R01CA226756"],"award-info":[{"award-number":["R01CA226756"]}]},{"name":"National Cancer Institute of the National Institutes of Health","award":["P30CA046592"],"award-info":[{"award-number":["P30CA046592"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: High-grade serous carcinoma (HGSC) is the leading cause of ovarian cancer-related mortality. It usually arises from fallopian tube epithelium, with a smaller subset arising in non-tubal sites including the ovary or peritoneum. The origin of HGSCs without evidence of tubal involvement remains unclear. Moreover, in women with genetic predisposition to developing HGSC, the additional protection afforded by prophylactic removal of the ovaries in addition to the fallopian tubes has not yet been established. Methods: We used a well-characterized genetically engineered mouse model (GEMM) of oviductal HGSC based on conditional, somatic inactivation of the Brca1, Trp53, Rb1, and Nf1 tumor suppressor genes (BPRN mice) to compare preventive effects for HGSC via bilateral salpingectomy versus bilateral salpingo-oophorectomy. We also explored the origins of non-tubal HGSCs in ectopic tubal-type epithelium (endosalpingiosis) present in the mouse ovaries and peritoneum. Results: While bilateral salpingectomy significantly reduced the incidence of HGSCs in the GEMM model, bilateral salpingo-oophorectomy completely prevented tumor development. We identified an example of HGSC with apparent origin in endosalpingiosis, implicating endosalpingiosis as a likely precursor for non-tubal HGSC. Conclusions: Our findings confirm the superiority of bilateral salpingo-oophorectomy over salpingectomy alone in reducing HGSC risk and affirm the rationale for surgical strategies to reduce HGSC risk in women carrying pathogenic variants of BRCA1\/2 and other genes associated with homologous recombination deficiency. Our findings also illustrate how work with GEMMs can advance new insights into HGSC pathogenesis.<\/jats:p>","DOI":"10.3390\/cancers17172759","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:09:53Z","timestamp":1756080593000},"page":"2759","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bilateral Salpingo-Oophorectomy Is Superior to Salpingectomy Alone in Preventing Non-Tubal Tumor Development in a Mouse Model of High-Grade Serous Carcinoma"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9792-7336","authenticated-orcid":false,"given":"Yali","family":"Zhai","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"Fearon","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA"},{"name":"Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA"},{"name":"Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109, USA"},{"name":"Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0500-9998","authenticated-orcid":false,"given":"Kathleen R.","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA"},{"name":"Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA"},{"name":"Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1038\/s41467-019-13116-2","article-title":"Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/PGP.0000000000000195","article-title":"Serous Tubal Intraepithelial Carcinoma (STIC)-like Lesions Arising in Ovarian Serous Cystadenofibroma: Report of 2 Cases","volume":"34","author":"Craig","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.pathol.2018.03.009","article-title":"High grade serous intraepithelial carcinoma arising in a benign ovarian serous cyst\u2014A bridge too far?","volume":"50","author":"Ramanayake","year":"2018","journal-title":"Pathology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.5145","article-title":"Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas","volume":"246","author":"Soong","year":"2018","journal-title":"J. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.fertnstert.2012.06.039","article-title":"What is endosalpingiosis?","volume":"98","author":"Prentice","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00000478-198203000-00003","article-title":"Endosalpingiosis in the omentum: A study of autopsy and surgical material","volume":"6","author":"Zinsser","year":"1982","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/path.4927","article-title":"High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease","volume":"243","author":"Zhai","year":"2017","journal-title":"J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ygyno.2022.03.030","article-title":"Aging accelerates while multiparity delays tumorigenesis in mouse models of high-grade serous carcinoma","volume":"165","author":"Hou","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1158\/0008-5472.CAN-19-2558","article-title":"Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts","volume":"80","author":"McCool","year":"2020","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1210\/en.2012-1340","article-title":"Minireview: Translational animal models of human menopause: Challenges and emerging opportunities","volume":"153","year":"2012","journal-title":"Endocrinology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/path.1719","article-title":"Location of inclusion cysts in mouse ovaries in relation to age, pregnancy, and total ovulation number: Implications for ovarian cancer?","volume":"205","author":"Tan","year":"2005","journal-title":"J. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/en.2007-0030","article-title":"Ovarian epithelial inclusion cysts in chronically superovulated CD1 and Smad2 dominant-negative mice","volume":"148","author":"Burdette","year":"2007","journal-title":"Endocrinology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1210\/en.2005-0697","article-title":"The development of a mouse model of ovarian endosalpingiosis","volume":"146","author":"Hutten","year":"2005","journal-title":"Endocrinology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/path.4783","article-title":"Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse","volume":"240","author":"Wu","year":"2016","journal-title":"J. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/path.5308","article-title":"Lineage tracing suggests that ovarian endosalpingiosis does not result from escape of oviductal epithelium","volume":"249","author":"Wang","year":"2019","journal-title":"J. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jnci\/djae300","article-title":"High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1\/2 germline pathogenic variant carriers","volume":"117","author":"Stroot","year":"2025","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41467-017-01217-9","article-title":"Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma","volume":"8","author":"Ducie","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_20","first-page":"762","article-title":"Primary peritoneal serous carcinoma: A clinicopathological and immunohistochemical study of six cases","volume":"5","author":"Hou","year":"2012","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/PGP.0000000000001018","article-title":"High-grade Serous Carcinoma Occurring in a Serous Cystadenoma on the Background of a Serous Tubal Intraepithelial Carcinoma (STIC)-like Lesion: A Case Report With Literature Review","volume":"43","author":"Novikov","year":"2024","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/gyno.1998.5275","article-title":"The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: Does the emperor have no clothes?","volume":"72","author":"Dubeau","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"viii28","DOI":"10.1093\/annonc\/mdt308","article-title":"Coming into focus: The nonovarian origins of ovarian cancer","volume":"24","author":"Dubeau","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41379-019-0370-1","article-title":"Natural history of ovarian high-grade serous carcinoma from time effects of ovulation inhibition and progesterone clearance of p53-defective lesions","volume":"33","author":"Wu","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_25","first-page":"1870834","article-title":"Primary Peritoneal Cancer Two Decades after a Bilateral Salpingo-Oophorectomy","volume":"2019","author":"Rodowa","year":"2019","journal-title":"Case Rep. Obstet. Gynecol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2005.01.039","article-title":"Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations","volume":"97","author":"Casey","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1634\/theoncologist.1-5-326","article-title":"Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate","volume":"1","author":"Piver","year":"1996","journal-title":"Oncologist"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e70037","DOI":"10.1002\/2056-4538.70037","article-title":"Pathogenesis of peritoneal high-grade serous carcinoma after risk-reducing surgery: A systematic review","volume":"11","author":"Gootzen","year":"2025","journal-title":"J. Pathol. Clin. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2018.11.033","article-title":"The fallopian tube, \u201cprecursor escape\u201d and narrowing the knowledge gap to the origins of high-grade serous carcinoma","volume":"152","author":"Soong","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e2147343","DOI":"10.1001\/jamanetworkopen.2021.47343","article-title":"Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention","volume":"5","author":"Hanley","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1940-6207.CAPR-14-0293","article-title":"Salpingectomy as a means to reduce ovarian cancer risk","volume":"8","author":"Daly","year":"2015","journal-title":"Cancer Prev. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ygyno.2018.04.564","article-title":"Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1\/2 mutations","volume":"150","author":"Nebgen","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_34","first-page":"e9301","article-title":"Prophylactic Bilateral Salpingo-oophorectomy in BRCA2 Mutation with Incidental Finding of Serous Tubal Intraepithelial Carcinoma (STIC) and Subsequent Diagnosis of Primary Peritoneal Carcinoma (PPC): A Case Report and Review of Current Literature","volume":"12","author":"Palaiologos","year":"2020","journal-title":"Cureus"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jmig.2020.09.020","article-title":"Salpingectomy for the Risk Reduction of Ovarian Cancer: Is It Time for a Salpingectomy-alone Approach?","volume":"28","author":"Boerner","year":"2021","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/ijgc-2023-004377","article-title":"TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: The TUBA-WISP II study protocol","volume":"33","author":"Steenbeek","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/jamaoncol.2021.1590","article-title":"Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1\/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial","volume":"7","author":"Steenbeek","year":"2021","journal-title":"JAMA Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2759\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:35:13Z","timestamp":1760034913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,24]]},"references-count":37,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cancers17172759"],"URL":"https:\/\/doi.org\/10.3390\/cancers17172759","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,24]]}}}